Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00408473
Other study ID # 1556-FLEC
Secondary ID
Status Terminated
Phase Phase 4
First received
Last updated

Study information

Verified date February 2007
Source Viatris Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to assess the efficacy of flecainide controlled release (CR) in the prevention of recurrent AF during 9 months of active treatment compared to placebo in patients with only one documented AF episode.


Recruitment information / eligibility

Status Terminated
Enrollment 256
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - History of first symptomatic & documented episode of AF - LVEF > 40% and not on AAD and in sinus rhythm at time of recruitment Exclusion Criteria: - History of more than 1 symptomatic documented AF episode, persistent or permanent AF. - History of ablation for previous AF - Reversible cause for AF (e.g.thyroid, alcohol, pulmonary embolism, surgery - Severe symptoms during AF episode (e.g.syncope, chest pain) - All types of treated arrhythmias other than AF - History of myocardial infarction (MI), coronary artery disease (CAD), heart failure (I, II, III and IV of New York Heart Association -NYHA- classification) or valvular diseases - Left ventricular ejection fraction (LVEF) = 40% - Bradycardia < 40 beats/min and all ECG abnormalities: PR> 240ms or QRS> 120 ms or QTc> 440 ms - Brugada syndrome - Conduction disturbances: complete bundle branch block (LBBB) or (RBBB), bifascicular block - 2nd or 3rd degree atrioventricular (AV) block - Sinus node dysfunction - Severe hypertension with:Systolic blood pressure = 180 mmHg, and / or· Diastolic blood pressure = 100 mmHg - Left ventricular hypertrophy (LVH) with septal thickness > 14 mm on Echocardiogram - Implanted pacemaker - Heart surgery within the last 6 months, or non-stable postoperative condition - Renal failure: serum creatinine = 150 µmol/l or creatinine clearance = 50 ml/min (Cockroft and Gault formula - Uncorrected electrolytic abnormalities - Have used recently in the last 3 months prior to the inclusion any of the following treatments: Oral amiodarone, Treatments that lengthen QT interval (e.g.Sultopride, Drugs causing torsades de pointe (e.g.mizolastine, pentamidine, sparfloxacin, moxifloxacin, Bupropion - Anti-hypertensive drugs other than permitted in the study: ACE-I, ARB (sartans) and DHP from Calcium channel blockers (CCB

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Flecainide


Locations

Country Name City State
Belgium Imeldaziekenhuis, Imeldalaan 9 Bonheiden
Belgium Hôpital St.-Joseph, Rue de la Duchère 6 Gilly
Belgium Virga Jesse Ziekenhuis, Stadsomvaart 11 Hassel
Belgium Regionaal Ziekenhuis Heilig Hart, Naamsestraat 105 Leuven
Belgium Clinique Sainte-Elisabet, Place Louise Godin 1 Namur
Bulgaria Department of Cardiology, MHAT Burgas AD, 73 Stefan Stambolov blvd Burgas
Bulgaria Cardiology Clinic and ICU, UMHAT "Dr. Georgi Stranski" EAD, 8a Georgi Kochev Str Pleven
Bulgaria Intensive Therapeutic Department, MHAT Ruse, 2 Nezavosimost str Ruse
Bulgaria Clinic of cardiology at Second MHAT, 120, Hristo Botev Blvd Sofia
Bulgaria Clinic of Cardiology, University Hospital 'Queen Giovanna', 8 Bialo More str Sofia
Bulgaria Department of Emergency and Intensive care, Military Medical Academy, 3 G. Sofiisky str Sofia
Bulgaria Department of Internal medicine II, University hospital "Aleksandrovska" , 1 G. Sofiyski str Sofia
Bulgaria Intensive care unit - MHATEM "Pirogov" , 21 Totleben Blvd Sofia
Bulgaria National Cardiology Hospital EAD, 65 Konjovitza Str. Sofia
Bulgaria CCU, University Hospital "St. Marina" , 1 Hristo Smirnenski Blvd Varna
France Centre Hospitalier Général, 22, boulevard Général Sibille Albi
France Hôpital d'Arras service de cardiologie, 57 avenue Wiston Churchill Arras
France Philippe CHEMIN, 49 rue du Bocage Bordeaux
France Hopital d'instruction des armées, rue Colonel Fonferrier Brest
France Centre Hospitalier Général, 516 avenue de Paris Cambrai
France Patrick GIRAUD, Bat C 132 av Gabriel Péri Cavaillon
France André CORBIN, 28 rue du Conte de la Garaye Dinan
France Centre Hospitalier du Leman, 3 avenue de la dame Evian-thonon
France Verschuersen Iordanka, 4 rue Béranger Fontainebleau
France Hôpital de Freyming Merlebach- Service de Cardiologie, 2 rue de France Freyming Merlebach
France Centre Hospitalier Général, 10 rue de la Charité Langres
France Jean Claude GICHTENAERE, 8 quai du Général Leclerc Martigues
France CHI Montfermeil, 10 rue du Gal Leclerc Montfermeil
France Résidence Médicale Les Roses, 57, route de Lavérune Montpellier
France Patrick KOHAN, 18 rue de la Commanderie Nancy
France Centre Hospitalier Regional, 1 rue du Friscaty Thionville
France Hôpital d'Instruction des Armées Sainte Anne, Boulevard Sainte Anne Toulon
France Centre médical, Promenade du petit Languedoc Villefranche de Rouergue
Germany Zentralklinic Bad Berka Gmbr Klinic fur Kardiologie- Leitender Arzt der Avteilung - Rhythmologie und invasive Elektrophysiologie, Robert Koch Allee 9 Bad Berka
Germany Director of Electrophysiology Laboratory - Department of Medicine - Cardiology- University of Bonn, Sigmund Freud Str 25 - Bonn
Germany Klinikum Coburg , Ketschendorfer Str. 33 Coburg
Germany Div Cardiology; University Hospital , Leipzigen St 44 - Magdeburg
Germany Oberarzt Medizinische Klinik und Poliklinik C IZKF Münster Kompetenznetzt Vorhofflimmern Universitätsklinikum Münster, Albert-Schweitzer-Straße 33, Münster
Germany Kardiologische Praxis, Magirusstr.49 Ulm
Netherlands "Academisch Ziekenhuis Maastricht, P. Debyelaan 25 Maastricht
Romania SPITALUL JUDETEAN-SECTIA CARDIOLOGIE, BRASOV, Str. Independentei Nr. 1 Brasov
Romania "SPITALUL CLINIC DE URGENTA ""ELIAS""-Clinica de Cardiologie, Str. Marasti, Nr. 17, sect 1 Bucuresti
Romania Spitalul Clinic Colentina-Departamentul Cardiologie, str. Stefan cel Mare, nr. 19-21, sector 2 Bucuresti
Romania "SPITALUL CLINIC de RECUPERARE, Str. Viilor Nr.46-50 Cluj - Napoca
Romania Centrul de Cardiologie , Str. Tabaci No. 1 Craiova
Romania CARDIO EXPERT, Str. Romulus, Nr. 62. Timisoara
Spain Hospital Universitario de Getafe, Carretera de toledo Madrid

Sponsors (2)

Lead Sponsor Collaborator
MEDA Pharma GmbH & Co. KG 3M

Countries where clinical trial is conducted

Belgium,  Bulgaria,  France,  Germany,  Netherlands,  Romania,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to the first relapse after randomization, with or without symptoms documented on ECG, Holter or "Self ECG unit" recording.
Secondary Total number of AF recurrences during the treatment period
Secondary Total number of patients in sinus rhythm at the end of the study
Secondary AF Burden
Secondary Number of emergency admissions due to AF recurrence
Secondary Cardiac Safety
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Completed NCT04571385 - A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) Phase 2
Completed NCT05366803 - Women's Health Initiative Silent Atrial Fibrillation Recording Study N/A
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT05442203 - Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease N/A
Completed NCT05599308 - Evaluation of Blood Pressure Monitor With AFib Screening Feature N/A
Completed NCT03790917 - Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
Enrolling by invitation NCT05890274 - Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO N/A
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT05316870 - Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation N/A
Not yet recruiting NCT06023784 - The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Recruiting NCT04092985 - Smart Watch iECG for the Detection of Cardiac Arrhythmias
Completed NCT04087122 - Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures N/A
Completed NCT06283654 - Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04546763 - Study Watch AF Detection At Home
Completed NCT03761394 - Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke N/A